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The proper function of astrocytes is critical for brain health as they are the most
abundant cells in the brain which monitor ion homeostasis, recycle neurotransmitters and
respond to tissue damage therefore disruption in astrocyte function can result in overall
detrimental effects and has been linked with neurodegenerative diseases. Titanium Dioxide
(TiO2) nanoparticles are currently the second most produced engineered nanomaterial in
the world with vast usage in consumer products leading to recurrent human exposure.
Animal studies indicate significant nanoparticle accumulation in the brain while cellular
toxicity studies demonstrate negative effects on neuronal cell viability and function.
However, the toxicological effects of nanoparticles on astrocytes have not been extensively
investigated. Therefore, we determined the toxic effect of three different TiO2
nanoparticles (rutile, anatase and commercially available P25 TiO2 nanoparticles) on
primary rat cortical astrocytes by evaluating events related to astrocytes functions and
mitochondrial dysregulation: (1) glutamate uptake and glutamate transporter gene
expression; (2) redox signaling mechanisms by measuring ROS production; and (3) the
expression patterns of dynamin-related proteins (DRPs) and mitofusins 1 and 2, whose

expression is central to mitochondrial dynamics. Anatase, Rutile and P25 were found to
have LC50 values of 88.22±10.56ppm, 136.0±31.73ppm and 62.37±9.06ppm respectively
indicating nanoparticle specific toxicity. All three TiO2 nanoparticles induced a significant
loss in glutamate uptake and down-regulation of glutamate transporter expression, which
is indicative of loss in vital astrocytes function. TiO2 nanoparticles also induced an increase
in reactive oxygen species generation, decrease mitochondrial membrane potential and
decrease mitochondrial dehydrogenase activity, suggesting mitochondria damage. TiO2
nanoparticle exposure altered expression patterns of DRPs at low concentrations (25ppm,
50ppm) and apoptotic fission at high concentrations (100ppm). Collectively, our data
provide compelling evidence that TiO2 nanoparticles exposure has potential implications
in astrocytes-mediated neurological dysfunction.
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Chapter 1 Introduction

1.1 Overview of Astrocytes in the Central Nervous system
The brain is composed of two main cell types; neuron and glial cells. The most
studied of the brain cells are neurons because of their known importance to organism
function through signal transduction in the central and peripheral nervous systems.
However, most of the tissue is made up of a variety of glial cells (microglia,
oligodendrocytes, and astrocyte). Astrocytes, also known as astroglia, are the most
abundant glial cell named so due to their distinct stellate-shape. They are found throughout
the central nervous system stretching into every region to contact all brain and blood vessel
cells. Originally named “brain glue” and assumed to only provide for tissue structural
integrity, much research over the past few decades has revealed a number of vital roles in
brain heath and dysfunction. Proper intercellular communications between astrocytes and
neurons is vital to prevent brain dysfunction and imminent neurodegeneration.1
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Figure 1: Astrocytes in vivo and in vitro. (A) Image by Wang and Nedergaard
showing the complex spatial organization of brain tissue with neurons (MAP-2; blue) and
a blood vessels contacted by astrocytes (eGFP; yellow) stretching out into all parts of the
tissue to collect signals and correct deviation from tissue homeostasis.2 Hippocampal
astrocytes in monoculture (GFAP; red) with their distinct star-like shape.
Recent studies have observed that astrocytes perform many vital roles in synaptic
formation/maturation, ion homeostasis and energy production. Studies in animal and in
vitro models strongly suggest that astroglia provide important chemical compounds useful
in the formation, maturation and turnover of neuronal synapses through a number of
mechanisms including their superior efficiency of cholesterol metabolism, provision of
growth factors and axon pruning.3 Astrocytes regulate extracellular ions through a series
of ion channels, hemichannels and receptors which trigger mechanisms of uptake and/or
blood brain barrier (BBB) manipulation. This assists in the passage of ions out or osmosis
of water into the brain through the BBB for the purpose of restoring ideal ionic conditions
for neuronal function.4 Manipulation of the BBB also allows astrocytes to encourage
transport of nutrients, especially oxygen and glucose, to provide for brain energy
production and consumption. This is a significant task as the brain consumes 20% of the
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total blood glucose and oxygen in support of cerebral activity. Astrocytes also metabolize
key substrates recognized as alternative sources of energy, such as glycogen and lactate,
with greater efficiency than neurons thereby providing for their high energy demands.5
These roles are highly regulated by the active signaling of neurons and neuronal activity,
which makes the understanding of astrocyte function and dysfunction an exciting avenue
of study in regard to neurological disease and prospective therapies.

1.2 Overview of Titanium Dioxide Use and Toxicity Studies
Titanium dioxide is a naturally occurring complex of titanium which for decades
has been collected, synthesized and utilized in a variety of industrial and commercial
applications. The most common forms of TiO2 utilized in industry are anatase and rutile,
each having unique atomic and crystalline form (Fig. 2) providing them with different
physicochemical properties. Therefore, each has strengths for a variety of applications.
Overall, both forms are well known for desirable properties such as good fatigue strength,
thermal stability, resistance to corrosion, as well as excellent optical, catalytic and
semiconductor properties.6 Due to its high refractive index, TiO2 has been used to provide
white color in a variety of products such as paint, sunscreen, toothpaste, pharmaceuticals
and a number of food items.7 Other industries have recognized excellent catalytic
properties of TiO2 which has been useful for self-cleaning thin films, water remediation
and energy production.6
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Figure 2: Nanoparticle crystal structure and atomic structure models. This
schematic shows the crystalline shape and atomic structure of the two most common forms
of TiO2 (structures assembled in Blender, adapted from Barnard et al8 and Bourikas et al9,
red and white balls represent titanium and oxygen atoms, respectively.) The desirable
physicochemical properties and toxicological profiles are strongly dependent on
nanoparticle crystalline form.
Early application of TiO2 utilized “fine” particles, a particle with diameter of 0.13um in size, which maintained all the desirable properties of the bulk material and several
studies showed these particles to be biocompatible with human and animal systems, even
to the point of utilizing fine TiO2 particles as a negative control in toxicity studies.10 As
technological advances allowed for easier and less expensive manufacture of
nanomaterials, materials with at least one dimension <100nm, manufacturers began to
substitute “fine” particles for “ultrafine” or “nanoparticles” due to enhancement of
desirable properties resulting from the increased surface area of the smaller particles. As
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of 2012, a study showed that TiO2 nanoparticles were the second most produced engineered
nanomaterial in the world.11 In 2013 the project on emerging nanotechnologies consumer
products inventory listed 1628 products or product lines, 10% of these products utilized
titanium nanotechnology.12 The increased utilization, thereby increased environmental
exposure and combined with the switch to the use of smaller particle sizes, the question
has been raised concerning whether particle size affects toxicity of nanoparticles. This
study explores the potential toxicity in organisms receiving TiO2 nanoparticle exposure
from their environment. Therefore a thorough understanding of nanoparticle exposure and
current toxicity knowledge was necessary.
Several reviews have been written in recent years highlighting important studies
regarding TiO2 nanoparticle toxicity in animal models through the common routes of
exposure: Ingestion, absorption, inhalation, and injection. 13, 14 In rainbow trout exposed to
TiO2 in their diet (0-100mg/kg) for 8 weeks, Ramden and coworkers observed Ti
accumulation in the gill, gut, liver, brain and spleen causing some biochemical
disturbances, such as changes in Cu and Zn and Na+ levels, and showing low clearance
from tissues such as the brain, liver, intestines and gills.15 Similarly, Wang and co-workers
demonstrated that a single oral administration of TiO2 nanoparticles in rats (5g/kg) resulted
in nanoparticle distribution and accumulation in various tissues including the stomach,
liver, kidneys, and brain.16 In hairless mice receiving topical treatment TiO2 nanoparticle
treatment Ti was found to accumulate mostly in the muscle, liver, lung, spleen and heart
with a small but significant amount of Degussa P25 crossing the blood brain barrier (BBB)
to accumulate in the brain, resulting in tissue damage.17 A multispecies study showed that
mice, rats and hamsters showed pulmonary inflammation and tissue lesions after chronic
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inhalation of high concentrations of TiO2 with the most drastic results shown in mice, then
rats, and then hamsters.18 Interestingly, damage and accumulation were noted in mice
brains after nasal inhalation of TiO2 nanoparticles suggesting particles may not require
access through the BBB but may be transported through nasal passages into each of the
major brain regions.19 Finally, 28 days after intravenous exposure to a single acutely nontoxic dose of (5mg/kg) a significant accumulation of nanoparticles was observed in the
liver and spleen. The low dose did not result in the increase of blood cytokines or tissue
damage.20 Overall, animal models show that regardless of entry route TiO2 can accumulate
in many major organs, including the brain, in most cases resulting in tissue damage and
biochemical disruption. However the complexity of the in vivo model limits the
biochemical knowledge regarding tissue specific disturbances. Therefore, we turn to in
vitro models for more specific focus on the reaction of individual cell types in contact with
TiO2 nanoparticles.
Several reviews have also been written regarding toxicity results in cell culture
models with exposure to TiO2 nanoparticles. Here I will summarize some of the major
results and common themes noted among different cell types associated with tissues
previously noted to be affected by nanoparticle accumulation.21

22

A majority of in vitro

studies have focused on epithelial cells especially associated with skin, lung and intestine
since those incorporate the common routes of entry for TiO2 nanoparticles. In human lung
cancer cells derived from the endothelium (A549 cells) anatase TiO2 nanoparticle exposure
was observed to result in concentration dependent decreased proliferation, DNA damage,
decreased mitochondrial membrane potential (MMP) and increased expression of
apoptosis markers Caspase 3 and 9.23 Human pulmonary epithelial cell line NCI-H292
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were utilized to show that Toll like receptor 4, an innate immune response to foreign
material, plays a key role in the uptake of P25 TiO2 nanoparticles and subsequent
inflammatory response.24 This observation reveals that innate receptors can increase
sensitivity to TiO2 nanoparticles contributing to the cell type specific variability in response
to nanoparticle presence. Study in keratinocytes, HaCaT cells, show uptake of anatase and
rutile particles into the cells cytoplasm with anatase nanoparticles observed in the nucleus
and extensive mitochondrial damage accompanied with increased reactive oxygen species
(ROS) production.25 A few studies have observed the cytotoxicity of TiO2 nanoparticles to
liver cells, the liver being a vital organ for detoxification of the blood and a major site of
nanoparticle accumulation, and observed that in 24 hours of exposure TiO2 nanoparticles
are not cytotoxic even at high concentrations of 250 µg/ml in BRL3A rat liver cells.26
However a study in L-02 human hepatocytes exposed to low levels of TiO2 nanoparticles
(1μg/ml) after 24 hours resulted in increased oxidative stress but not chromosome damage
or apoptosis27 suggesting that a stress response is triggered in the cells at concentrations
below the cytotoxic or genotoxic level. In mouse fibroblasts, a common cell type which
synthesizes extracellular matrix, nanoparticle internalization and generation of ROS was
observed in low concentrations (0-30μg/ml) while significant cell death was observed only
in response to high concentration (300 and 600μg/ml).28 The various responses and
sensitivities to TiO2 is to be expected since cells perform different roles in tissues, making
some cell types more sensitive to alterations in the cellular environment than others. It is
therefore important to study the reaction of as many cell types as possible especially in
tissues which are highly sensitive to injury such as the brain.
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Chapter 2 Nanoparticle Characterization in Culture
Media

2.1 Introduction
Nanotoxicologists agree that nanomaterial toxicity is strongly dependent on the
intrinsic and aggregating properties of nanomaterials therefore, for the sake of consistency
and reproducibility of results, a basic nanoparticle characterization is an important part of
any nanotoxicity study.29 In the beginning of this emerging field, lack of uniformity in term
definitions, nanoparticle characterization, and treatment methods made it difficult to
compare results, leading to disagreements regarding the safety of nanomaterial usage.
However, in the early 2000’s several leaders in the field established reviews to define terms
and establish methods bringing standardization to the field.29, 30 Along with the benchmarks
they established, these researchers emphasized the importance of physicochemical
properties, especially size, shape and structure, on nanoparticle toxicity and therefore
strongly advised that researchers provide physicochemical properties of nanomaterials.
Some of these properties may be conveyed by the manufacturer, contingent on whether the
material was purchased or made in house. However characterization of nanoparticles under
testing conditions, such as aggregation in administration solution, should be performed by
the research and can be helpful for retrospective interpretation of data.
In this study we characterized three commercially available TiO2 nanoparticles
(Anatase, Rutile and P25) by transmission electron microscopy (TEM) and dynamic light
scattering (DLS) in order to provide physicochemical characterization and to compare our
nanoparticles to previously published work for the nanoparticles we would utilize in future
toxicity studies. TEM was performed to observe the particles for nanoparticle shape on a
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per particle basis. DLS was utilized to report the aggregate size and zeta potential
(aggregate state) in physiologically relevant serum-free (neuron media) and serum
containing (astrocyte media) cell culture medium.

2.2 Materials and Methods
2.2.1 Preparation of Nanoparticle Suspensions
The nanoparticles utilized for this study were Degussa P25 [Sigma Aldrich, St.
Louis, MO], Anatase, or Rutile [Mk Nano, Mississauga, Ontario, Canada] TiO2
nanoparticles. Prior to suspension all nanoparticles were sterilized by UV treatment
overnight. Stock suspensions of 1000ppm were made in autoclaved 1X PBS by sonication
[FS30D Fisher Scientific] for 30minutes and stored at 4°C. For experiments, the stock
suspensions were diluted in culture media and sonicated for 30minutes.
2.2.2 Transmission Electron Microscopy
Nanoparticles were suspended in deionized water, deposited on carbon coated
copper grids [Ted Pella, Redding, CA] and visualized with a Hitachi H7500 Transmission
Electron Microscope.
2.2.3 Culture Media Preparation
Culture media was prepared as for cell culture studies. In short, for astrocyte culture
media, DMEM [MP Biomedicals], 10% Heat Inactivated Horse Serum [PAA Lab], 1%
HEPES [Media Tech], 1% penicillin-streptomycin [Life Technologies], and 1% LGlutamine [Life Technologies] were combined, pH adjusted to 7.4 with 1M HCl or NaOH,
and filter sterilized with a 0.22μm filter [Thermo Scientific]. For neuron culture media,
Neurobasal media [Life Tech] with 2% B27-Supplement [Invitrogen], 1% 200mM LGlutamine, 0.0055mg/ml glucose [Sigma-Aldrich] and 1 % penicillin-streptomycin was
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combined, pH adjusted to 7.4 with 1M HCl or NaOH, and filter sterilize with a 0.22μm
filter. These were stored at 4°C until needed for measurements.
2.2.3 Mean Effective Diameter and Zeta Potential
ZetaPALS [Brookhaven instrument, Holtsville, NY] was utilized to determine
nanoparticle effective diameter and Zeta potential [PALS Zeta Potential Analyzer,
Smoluchowski model] at the treatment concentrations of 25ppm, 50ppm and 100ppm.
Nanoparticle solutions were made with culture media at pH 7.4 as outlined for cell culture
experiments. All size measurements were performed at 25°C, at a scattering angle of 90°
and analyzed via intensity and volumetric distribution.

2.3 Results and Discussion
2.3.1 Nanoparticle Crystalline Structure
TEM was employed to characterize the individual crystal shapes and sizes of the
TiO2 nanoparticles (Fig 3) in the absence of solution based interactions for a per particle
analysis. Anatase TiO2 nanoparticles were observed to be the characteristic spherical
crystal structure while rutile nanoparticles had typical rod-like crystal structure as has been
observed in previous studies.31, 32 The Anatase and Rutile TiO2 nanoparticles utilized for
this study were both reported as 50nm in diameter by the manufacturer, thus allowing for
observations of crystal structure influence on nanoparticle toxicity independent of particle
size. P25 nanoparticles are the third variation of TiO2 nanoparticles chosen for this study
due to their popular use commercially, industrially and in toxicity studies. P25, a 3:1
mixture of anatase and rutile, has structural characteristics of both anatase and rutile and
was reported to be 21nm in diameter. Our images had similar shape as previously reported
P25 nanoparticles.33
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Figure 3: Nanoparticle characterization images of per particle form. TEM images
of Anatase (A), P25 (B), and Rutile (C) TiO2 nanoparticles. Scale bar = 100 nm
2.3.2 Nanoparticle Dependent Aggregation Profile in Physiologically Relevant
Media
In addition to characterizing the TiO2 particles in a per particle basis, in the absence
of solution interactions, we then performed DLS and Zeta potential analysis to uncover the
solution dependent behavior of the particles. Previous reports have shown that TiO2
nanoparticles agglomerate in cell culture media.34 To compare the level of agglomeration
of the TiO2 nanoparticles in physiologically relevant conditions, in the presence of proteins
and divalent ions, we studied the agglomeration of the TiO2 nanoparticles in astrocyte and
neuron culture medium. The nanoparticle suspensions were characterized using DLS for
hydrodynamic diameter of the aggregates and zeta potential to discern nanoparticle charge
and colloidal stability. As shown in Table. 1, at a concentration of 50ppm in astrocyte
culture media P25, anatase and rutile nanoparticles aggregated to average diameter of
approximately 370nm, 550nm, and 360nm, respectively and at a concentration of 50ppm
in neuron culture media the average diameter was approximately 380nm, 530nm, and
340nm respectively. We observed that the average hydrodynamic diameter depended on
crystalline form, but not on concentration, indicating that the relative concentrations would
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be reliable for our study and that the cells treated with serum vs serum free media would
be interacting with similar nanoparticle aggregates. It was observed that the type of crystal
structure of the particles (anatase vs rutile) and the relative composition of the three forms
of nanoparticles have a greater influence over aggregation size than the media composition.
This is similar to other studies where it was observed that nanoparticles aggregate to
diameters in the range of 300-600nm in media containing serum and it has also been
previously reported to have a nanoparticle form dependence.31, 32, 35 However, our results
show that the serum-free media, caused a similar aggregation to that of the serum media,
while literature varies greatly on the aggregate diameter in serum free conditions.31, 36
According to the manufacturer the specifics of the B-27 supplement added to the neuron
media is confidential but they disclose that it contains some proteins, including BSA, which
has been speculated to play a role in particle aggregation in previous studies37, therefore
our “serum free” media is different than the previously referenced “serum free” solutions
studied which were protein free.
Zeta potentials were also measured for the three TiO2 nanoparticles (Table. 1). The
zeta potential values did not significantly change depending on forms of the nanoparticles,
concentration, or medium. In all cases the weakly negative net charge of the nanoparticles
highlighted their inherent colloidal instability driven by favorable aggregation forces. Our
observed zeta potential results, in both mediums, were similar to previous studies in serum
containing media32, 35 and very different from the serum free study36 which observed a
strongly positive zeta potential. Our characterization provides us with valuable information
about the intricate characteristics of the nanoparticles, including size, charge and driving
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forces for aggregation, that provide valuable insight for data analysis and comparison to
previous studies.

2.4 Conclusion
We conclude from our observations that the nanoparticles we purchased are similar
to TiO2 (P25, anatase and rutile) nanoparticles utilized in previous toxicity studies. These
nanoparticles have similar structure as visualized with TEM and similar aggregation states
in protein containing, physiologically relevant cell culture media as observed with DLS as
has been observed in previously published toxicity studies.

Table 1: Nanoparticle aggregate characterization in physiologically relevant cell culture media. Particle size provided by
manufacturer indicated in methods. Hydrodynamic diameter, zeta potential, and conductance at three concentrations (25ppm,
50ppm and 100ppm) measured in serum containing (Astrocyte) and serum free (Neuron) culture media. Data are expressed as the
mean ± standard deviation of two independent samples.
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Chapter 3 Toxicity and Functional Impairment in

Primary Astrocytes Cultured With Titanium Dioxide
Nanoparticles
3.1 Introduction
Titanium Dioxide (TiO2) nanoparticles are the second most produced engineered
nanomaterial in the world with a vast majority utilized for cosmetics, including sunscreen,
and consumer products.11, 38 The unique properties of TiO2 nanoparticles have also proven
useful in applications of air and water purification and energy storage7, providing increased
opportunities for commercial and industrial exposure to these nanoparticles. This increased
human and environmental contact with TiO2 nanoparticles has led to an intense scrutiny of
its biocompatibility resulting in many studies, suggesting a need for concern.13, 39
Animal and cell studies indicate the possibility of harmful effects resulting from
human exposure to TiO2 nanoparticles. Wang and co-workers demonstrated that oral
administration of TiO2 nanoparticles in rats resulted in nanoparticle distribution and
accumulation in various tissues including the brain.16 Intranasal exposure of TiO2
nanoparticles also demonstrated high accumulation of the nanoparticles in different regions
of the brain resulting in the increase of Glial Fibrillary Acidic Protein (GFAP) positive
cells, oxidative stress, and brain tissue damage.19Wu and co-workers exposed TiO2
nanoparticles to PC12 cell lines and observed decreased cell viability, generation of
reactive oxygen species (ROS), loss of mitochondrial membrane potential (MMP) and
increased expression of biomarkers associated with apoptosis/cell death.32 Long et al.
demonstrated a cell-dependent effect due to exposure to TiO2 nanoparticles wherein BV2
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microglia cell lines had a faster decrease in viability compared to N27 neuronal cell lines
suggesting that microglia are more susceptible to TiO2 nanoparticles.40 Together, these in
vitro and in vivo studies indicate that exposure to TiO2 nanoparticles results in a certain
degree of toxicity. However, the majority of previous studies have focused on neurons and
neuronal cell lines leaving a significant gap of knowledge regarding toxicity mechanisms
in other brain cells including astrocytes.
Astrocytes are distinct stellate-shaped brain cells found throughout the central
nervous system that perform many vital roles for proper brain function. Recent studies
demonstrated that astrocytes receive signals from neurons, actively respond to neuronal
activity with cytosolic calcium elevations evoked by neurotransmitters, such as glutamate,
gamma-aminobutyric acid (GABA), norepinephrine, dopamine, acetylcholine, serotonin,
adenosine triphosphate (ATP), and nitric oxide41 and are the primary cell type for some
neurotransmitter

recycling.

For

instance,

glutamate,

an

essential

excitatory

neurotransmitter utilized for neuronal signal transduction, is an especially important task
of astrocytes as neurons lack an essential enzyme for net conversion of glutamate from
glucose and therefore rely on astrocyte metabolism to provide sufficient quantities for
function. Furthermore, neurons cannot efficiently clear glutamate from the synaptic cleft
after a signal transduction event and therefore rely on astrocyte clearance for the prevention
of excitotoxicity. Through glutamate recycling astrocytes also play into the overall brain
energy production as glutamate enters and exits the citric acid cycle by conversion to αketoglutarate thereby producing adenosine triphosphate (ATP), the major biomolecule
which supplies energy for all cellular processes.42 Another interesting role is their response
to and eventual restoration of homeostasis after tissue injury.43Hence, astrocytes might
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possess the key to understanding the underlying mechanisms that mediate brain injury due
to exposure to TiO2 nanoparticles. Therefore, it is important to understand the mechanisms
of toxicity in astrocytes as it affects their ability to function.
One mechanism that has been observed in numerous previous in vivo and in vitro
studies is the increase in intercellular ROS and oxidative stress after treatment with TiO2.
Oxidative stress occurs when intracellular levels of ROS exceed the innate antioxidant
actions of the cell. This can result in oxidative damage to proteins, lipids and DNA and has
been implicated in a number of neurodegenerative diseases.44 In this study we sought to
assess the impact of low, physiologically relevant concentrations of TiO2 nanoparticles on
cellular activity of primary cortical astrocytes. We utilized three commercially employed
TiO2 nanoparticles (P25, Anatase, and Rutile), to investigate nanoparticle specific
perturbation in an explicit range of concentrations mimicking TiO2 nanoparticle
accumulation. Additionally, we evaluated the effect of TiO2 nanoparticles exposure on
ROS production, a strong indicator of perturbations in normal function. Our findings
demonstrate toxic effects of TiO2 nanoparticles on cellular function and health in primary
astrocytes.

3.2 Materials and Methods
3.2.1 Isolation, Seeding and Treatment of Primary Neurons and Astrocytes
Primary Cortical Neurons and Astrocytes were prepared from 1-3day-old SpragueDawley rat pups [Charles River, Sulzfeld, Germany] in compliance with UNL’s IACUC
protocol 1046 and according to protocol45, 46 with slight modifications. In short, the tissue
was digested with 0.025% Trypsin [Life Technologies] and 0.0016% DNase [Roche]
which was quenched by Astrocyte culture media (DMEM [MP Biomedicals], 10% Heat

18
Inactivated Horse Serum [PAA Lab], 1% HEPES [Media Tech], 1% penicillinstreptomycin [Life Technologies], 1% L-Glutamine [Life Technologies]). The inactive
trypsin was removed by centrifugation at 1700rpm for 5minutes, then cells were suspended
in plating media and gently triturated with glass pipette. The cells were then passed through
a 70μm cell filter, centrifuged, suspended in neuron culture media (Neurobasal media [Life
Tech] with 2% B27-Supplement [Invitrogen], 1% 200mM L-Glutamine, 0.0055 mg/ml
glucose [Sigma-Aldrich] and 1 % penicillin-streptomycin) or Astrocyte culture media and
counted by trypan blue stain with a hemocytometer. Neurons were seeded on poly-LLysine coated tissue culture plates at a cell density of 2,000 cells per cm2 in Neuron culture
media and Astrocytes were seeded on poly-L-lysine coated tissue culture plates at a cell
density of 500 cells per cm2. The first media change was performed on day in vitro (DIV)
two in both cell types and every four days following until experiments were performed.
Neurons received half media changes per well in order to preserve the sensitive neurite
network and astrocytes received full media changes with vigorous shaking to remove other
glial cell types. Neurons were utilized on DIV 10-12 after extensive neurite networks had
been established. Astrocytes were utilized on DIV 3-5 after obtaining 70% confluence.
3.2.2 Lethal Concentration Assay
The concentration lethal to 50% of astrocytes (LC 50) was determined utilizing the
MTT [3-(4,5-dimethyldiazol-2-yl)2,5 diphenyl Tetrazolium Bromide] [Life Technologies]
Assay. It is a colorimetric assay that evaluates the mitochondrial conversion of the MTT
salt. In short, after 24hours of nanoparticle exposure the culture media was aspirated and
5mg/ml MTT working solution in DMEM incubated on live cells at 37°C for 3hours. Lysis
buffer (0.1N HCl in Isopropanol) was added in a 5:1, lysis buffer to MTT solution, ratio.
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The absorbance values were read at 570/630nm in an AD340 plate reader [Beckman
Coulter, Indianapolis, IN].
3.2.3 Cellular Morphology with Phase Contrast Imaging
Morphology of live cells were assessed using an Axiovert 40 CFL [Zeiss, Germany]
and images taken with a Progres C3 [Jenoptick] camera.
3.2.4 Gene Expression
Total RNA was isolated using Trizol [Life Technologies] according to the
manufacturer’s instructions. The quality and quantity were determined by ND-1000
spectrophotometer [NanoDrop Technologies Wilmington, DE] and reverse transcribed
using iSciptTM cDNA synthesis kit [Bio-Rad Laboratories] by manufacturer’s
instructions.
Quantitative Real Time PCR was performed using SYBR Green Master Mix
[Applied Biosystems, Foster City, CA] in an epgradient S Mastercycler [Eppendorf]. The
PCR program was set to the following: 10minutes at 95°C, 40-60 cycles of 95°C for
15seconds followed by annealing at 60°C for 15seconds and elongation at 72°C for
60seconds, and finally 95°C for 15seconds to end. The primers of interest obtained from
Integrated NDA Technologies [Coralville, IA] with the following sequences: GLAST
(Forward

5’-CTACTCACCGTCAGCGCTGT-3'

and

Reverse

5’-

AGCACAAATCTGGTGATGCG-3'). GAPDH (Forward 5’ ATG ATT CTA CCC ACG
GCA AG 3’ and Reverse 5’ CTG GAA GAT GGT GAT GGG TT 3’) was measured as
reference. The ΔΔCT method was utilized for analysis of each sample. Results reported as
normalized to the average expression of untreated cells.
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3.2.5 Glutamate Uptake Assay
The uptake of [3H] glutamic acid was used to determine change in glutamate uptake
experienced by TiO2 nanoparticle treated astrocytes. The treatment media was removed
and replaced by serum free high glucose DMEM containing 50μM glutamate and 18.5kBq
of [3H] glutamic acid [Perkin Elmer]. Uptake was terminated after 15minutes by removal
of working solution. Cells were washed twice with ice-cold PBS. Cells were then lysed in
10mM NaOH containing 0.1% Triton X-100 and 300µl of lysate was assayed for 3H by
liquid scintillation counting. The protein content was assayed using Bradford assay.
Results were reported as CPM/ µg protein.
3.2.6 Reactive Oxygen Species Generation
CM-H2DCFDA is a fluorescent indicator activated by the presence of ROS. The
culture media was aspirated and the cells washed with warm 1X PBS. 10μM CMH2DCFDA [Life Technologies] in DMEM was added to each well and incubated at 37°C
for 30minutes. Cells were washed 3 times with PBS followed by fluorobrite media [Life
Technologies] added to each well. The bottom of the well was read at excitation 495nm
and emission 529nm with a SLFA plate reader [Biotek, Winooski, VT]. The results were
reported as a fraction of the average untreated intensity.
3.2.7 Statistical Analysis
All data is presented as the mean ± the standard deviation. Statistical comparisons
between treatments utilized Sigma Plot ANOVA (Dunnett’s Method) for analysis. Pool
size was as indicated in figure description.
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3.3 Results and Discussion
3.3.1 Determining Lethal Concentration in Primary Astrocytes
We utilized the lethal concentration assay at 24hours (hr) TiO2 nanoparticle
exposure, to determine concentrations of acute toxicity to primary rat cortical astrocytes.
As seen in Figure 4, the LC50 values of P25, anatase and rutile TiO2 nanoparticles were
62.37±9.06ppm, 88.22±10.56ppm, and 136.0±31.73ppm, respectively. Our results are in
agreement with other studies indicating that anatase crystalline phase is more toxic than
rutile.32 This result provided us with values of acute toxicity that were useful in determining
concentrations for further studying mechanisms of toxicity. Therefore, all subsequent
studies were carried out using three different concentrations of TiO2 nanoparticles (25ppm,
50ppm, and 100ppm) with 24hr exposure that is reflective of the LC50 data. These
concentrations are in a relevant sub-acute toxic range compared to previous studies that
have been carried out using higher concentrations to study the effect of TiO2 nanoparticle
exposure on neuronal cells.21 Previous reports have used high concentrations of the
nanoparticles and were thus unable to discern mechanistic response beyond loss of
viability.21

Figure 4: Lethal concentration. Lethal concentration was quantified at 0ppm, 25ppm, 50ppm, 100ppm, 300ppm, 500ppm, 700ppm,
and 1000ppm nanoparticle. P25 was observed to be the most lethal nanoparticle after 24hr treatment followed by Anatase and Rutile
as determined by calculating the LC50 values utilizing sigma plot analysis. (N = 6).
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3.3.2 Nanoparticles Induce Loss of Viability and Morphology in Astrocytes
To compare the effect of TiO2 nanoparticles to primary neuron and astrocyte
viability and morphology phase contrast imaging (Fig. 5 and 6). Changes in cellular
morphology represent a strong qualitative indicator of cellular injury and viability loss.47
Neurons appeared to be insensitive to nanoparticle presence as a change in morphology
and viability was not observed in 24hr (Data not shown). Even after 5 days in culture an
insignificant loss in morphology and viability was observed for all nanoparticle forms and
all concentrations except slight loss of neurite outreach in neurons treated with 100ppm
P25 and anatase nanoparticles, indicating that the neurons were mostly indifferent to the
presence of nanoparticles (Fig 5). However, we observed concentration- and phasedependent changes in morphology and viability of astrocytes in the presence of TiO2
nanoparticles after 24hr (Fig 6). Exposure to 100ppm of P25 and anatase demonstrated the
most profound changes in cell morphology and viability, as compared to 100ppm rutile. In
addition, the change in morphology, and subsequently cell viability, was concentration
dependent and correlated well with the LC50 values. Similar results have been observed in
other cell lines and mixed cultures that observed reduced cell size and rounded shape prior
to cell detachment.36, 47 Overall, these experiments validated that we were working in the
sub-acute realm and that astrocytes experienced more sensitivity to TiO2 nanoparticle
presence than neurons.

Figure 5: Effect of TiO2 nanoparticles on the morphology and viability of Neurons 5days after TiO2 treatment. Day 1-4 did not
exhibit drastic change in morphology and viability (as indicated by the survival of delicate neurite networks). By day 5 with
nanoparticles the neurite network of neurons treated with P25 and Anatase 100ppm appeared to break down while cells treated with
Rutile 100ppm nanoparticles still have many neurites intact. Cells treated with 25ppm and 50ppm of all three nanoparticles types
show much less change in morphology after 5days. Scale bar = 200μm.
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Figure 6: Effect of TiO2 nanoparticles on the morphology and viability of astrocytes. Change in astrocyte viability and
morphology was assessed with phase contrast images 24hr after TiO2 treatment. A concentration- and form-dependent trend was
observed with exposure to P25 and anatase 100ppm showing the greatest change in morphology and exposure to rutile 100ppm
TiO2 nanoparticles less change. Astrocytes treated with all three nanoparticles at concentrations 25ppm and 50ppm show much
less change in morphology than 100ppm. Scale bar = 200μm.
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3.3.3 Nanoparticles cause Loss of Glutamate Uptake and Glutamate
Transporter Expression
To study the effect of TiO2 nanoparticle exposure on primary astrocyte function,
we measured glutamate uptake and GLAST gene expression (Fig 7). Astrocytes are the
major cell of the brain to clear and process glutamate for future neuron function and
prevention of neural excitotoxicity therefore loss of this function could have negative effect
on overall brain health.1,
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We quantified the glutamate uptake by astrocytes using

radiolabelled glutamate upon 24hr exposure to three concentrations (25ppm, 50ppm, and
100ppm) and types (P25, anatase, and rutile) of TiO2 nanoparticles (Fig 7A) and observed
significant concentration and type dependent loss. The exposure of astrocytes to 25ppm,
50ppm, and 100ppm of P25 resulted in approximately 30% reduction in glutamate uptake.
Astrocytes treated with 50ppm and 100ppm of anatase resulted in 45% reduction in
glutamate uptake while 25ppm did not affect glutamate uptake in astrocytes compared to
untreated cells. The exposure of astrocytes to rutile resulted in negligible reduction in
glutamate uptake in 25ppm and 50ppm while 100ppm resulted in 40% reduction in
glutamate uptake. These data indicate that TiO2 nanoparticle exposure exerts both
concentration- and type-dependent effect on glutamate uptake of astrocytes, with P25
causing the highest damage to astrocytes biology even at low concentration of 25ppm.
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Figure 7: Effect of TiO2 nanoparticles on glutamate uptake. Decrease in glutamate
uptake and mRNA expression of glutamate transporter GLAST was observed indicating
loss of important cellular functions in astrocytes by 24hr TiO2 nanoparticles exposure. N
= 3, “*” indicates P<0.05.
To further investigate the mechanisms leading to reduction in glutamate uptake, we
measured the gene expression levels of glutamate/aspartate transporter (GLAST).
Glutamate homeostasis is maintained by neuron-astrocyte interaction via several glutamate
transporters and is a key metabolic function of astrocytes and neurons at the mitochondrial
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level.48 Glutamate transporters are classified under two categories, namely the Excitatory
Amino Acid Transporters (EAATs) and the Vesicular Glutamate Transporters (vGLUTs)
which are responsible for maintaining low physiological extracellular glutamate levels.49
Five subtypes have been identified in rodents and humans including GLAST that is
predominately expressed in astrocytes and is required for regulating the glutamate uptake
behavior of these cells.50
To understand the effect of TiO2 nanoparticle exposure on glutamate transport, we
investigated the relative gene expression of GLAST (Fig 7B) after 24hr of exposure to the
different TiO2 nanoparticles. We observed significant concentration- and type-dependent
down-regulation of GLAST gene expression. The exposure of astrocytes to 25ppm, 50ppm,
and 100ppm of P25 resulted in 40%, 75%, and 75% fold down-regulation of GLAST
expression, respectively. The same concentrations of anatase TiO2 nanoparticles resulted
in 35%, 45%, and 60% fold down-regulation of GLAST expression, respectively. Lastly,
exposure of astrocytes to 25ppm, 50ppm, and 100ppm of rutile resulted in 40%, 50%, and
50% fold down-regulation of GLAST expression, respectively. From these data, we
hypothesize that exposure to TiO2 nanoparticles results in significant damage to the
glutamate transporter expression resulting in the reduction in glutamate uptake in
astrocytes. This is suggestive of the damage that TiO2 nanoparticles elicit on astrocytes
function. The ability to produce, uptake and recycle glutamate is a vital role of astrocytes
in the brain as they interact with neurons for healthy brain functions.1,

42

Hence, the

compromise of this function through TiO2 nanoparticle exposure is indicative of potentially
detrimental effect to brain function and increased risk toward neurodegenerative process.
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3.3.4 Nanoparticles Induce Oxidative Stress in Primary Astrocyte
To further investigate the damage caused by TiO2 nanoparticle exposure in primary
astrocytes, we determined intracellular levels of ROS when exposed to TiO2 nanoparticles
for 24hr. ROS generation has previously been observed to accompany loss of glutamate
and glutamate transporter expression linking induced mitochondrial stress to loss of
astrocyte function and could therefore be an attribute of TiO2 nanoparticle toxicity.51
Concentration- and type-dependent increase in ROS production (as indicated by enhanced
CM-H2DCFDA fluorescence) was observed following the 24hr exposure of primary
astrocytes to TiO2 nanoparticles (Fig 8). The exposure of astrocytes to 100ppm of P25 and
anatase resulted in the highest CM-H2DCFDA fluorescence while exposure of 100ppm of
rutile did not lead to a significant increase in ROS, as compared to untreated cells. The
higher production of ROS in P25 and anatase indicate that primary astrocytes are under
high stress.52 This observation is comparable to other studies that have demonstrated a
similar effect of TiO2 nanoparticle exposure on oxidative stress in both animal and cell
models.53, 54
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Figure 8: Oxidative stress induced by TiO2 nanoparticles after 24hr. ROS generation was
observed to have a concentration and form dependence. Significant ROS generation was
observed in the cells treated with 100ppm and 50ppm P25 and Anatase nanoparticles after
24hr indicative of oxidative stress in primary astrocytes. N = 5, “*” indicates P<0.05.

3.4 Conclusion
Overall, we observed that culture of primary astrocytes with commercially and
industrially relevant TiO2 nanoparticles at low concentrations resulted in concentrationand type-dependent cytotoxic effects in viability, morphology and cell function. The
glutamate uptake and GLAST gene expression were significantly compromised due to
TiO2 nanoparticles exposure even at concentrations as low as 25ppm. These alterations
correlate with an increase in the amount of intracellular ROS production. Therefore, we
conclude that TiO2 nanoparticles in sub-acute toxic concentrations could contribute to loss
of astrocyte function and, potentially, neurodegeneration.
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Chapter 4 Mechanisms of Toxicity of Titanium Dioxide
Nanoparticles in Culture with Primary Astrocytes

4.1 Introduction
Mitochondria are essential organelles in the cell primarily known for their involvement
in cellular bioenergetics and metabolism. More recently, they have been recognized for
organelle communication and initiation of programmed cell death. The signaling
mechanisms from mitochondria are especially fascinating since they prevent the cell from
committing to biological processes that cannot be supported by the metabolic actions of
the mitochondria. ROS is a byproduct of ATP production and also used as signals to
regulate a wide variety of cellular processes such as oxygen sensing, autophagy, and
immune response.55 Although ROS is a common component of cellular processes it is
typically matched by antioxidant molecules to maintain a tolerable level for prevention of
oxidative damage. However, ROS imbalance can lead to elevated intracellular ROS which
is an accepted early sign of altered mitochondrial function. Chronic elevated levels of
intracellular ROS can lead to a state of oxidative stress which has been implicated in cell
death and a variety of neurodegenerative diseases.56,

57

Therefore, disturbances in

mitochondrial function is insightful to understanding TiO2 nanoparticles toxicity and their
potential role in neurodegeneration.
A unique and vital feature of mitochondria is the constant dynamic nature utilized to
rejuvenate and meet the energy requirements of the cell. The balance of merging (fusion)
and dividing (fission) maintains the mitochondrial dynamics facilitating cell bioenergetics
demand and eliminating injured mitochondria thereby assuring sufficient energy supply for
proper cell function. Fusion, mediated by membrane-anchored dynamin family members
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mitofusins (Mfn 1 and 2), is required for mitochondrial (mt) DNA maintenance because it
allows mtDNA exchange and protects the mtDNA from damage during stress.58, 59 Fission,
mediated by cytosolic dynamin family member Dynamin-related protein 1 (Drp1), is
essential for mitochondrial distribution and selective elimination of damaged mtDNA.
Mitochondria utilize fission in response to extensive and persistent mitochondrial damage,
as abundant fission can result in the release of factors to initiate the cascade for cellular
apoptosis.60
The disruption of this delicate balance has been observed to have positive and negative
effects in response to cellular stressors. Excessive fission, characterized by overexpression
of fission marker Drp1, is commonly a sign of irreparable damage as the cell is set in
motion toward apoptotic programmed cell death.61 The production and release of proapoptotic factors such as Bcl-2 and cytochrome C is strongly dependent on the production
of Drp1 as shown by delayed release when the Drp1 gene expression is eliminated.62
Excessive fusion, characterized by an increase in fusion markers, has been observed to
promote mitochondrial function and prolong cellular survival in response to specific low
levels of stress including stressors with potential to induce apoptosis.59 Furthermore, Wang
et al observed overexpression of Mfn2, resulting in increased mitochondrial fusion, to
prevent glutamate excitotoxicity in primary rat motor neurons, showing the mitochondrial
fusion as pro-survival in the presence of stress. However, Uo et al found that eliminating
the expression of Drp1 in primary cortical neurons induces hyperfused mitochondrial
morphology and a significant decrease in cell viability, solidifying the importance of the
careful balance maintained by the mitochondria.63 Thus, studies of mitochondrial dynamics
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in brain cells emphasizes that the careful balance must be maintained for cellular function
and survival which is strongly stressor dependent.
In the presence of stress induced by TiO2 nanoparticles, two previous studies have
observed mitochondrial injury and altered bioenergetics function in astrocyte cell lines.
These studies were performed with 96% anatase nanoparticles at moderately high
concentrations (20μg/ml) in C6 and U373 cell lines, a mouse and human glioma cell line,
observing internalization of nanoparticles, increased intracellular ROS, decreased
mitochondrial membrane potential, and apoptosis.47, 54 However, no studies have observed
the effect of TiO2 nanoparticles on mitochondrial dynamics in primary astrocytes.
Therefore, the aim of this study was to understand the effect of three commercially
available nanoparticles (P25, Anatase and Rutile) at sub-acute toxic concentrations
(25ppm, 50ppm, and 100ppm) on the mitochondrial health and dynamics of primary rat
cortical astrocytes. We monitored mitochondrial health by observing the change in
mitochondrial membrane potential and mitochondrial dehydrogenase activity and observed
change in mitochondrial dynamics by monitoring change in Drp1, Mfn1 and Mfn2 gene
expression after 24 hour incubation with low levels of TiO2 nanoparticles.

4.2 Materials and Methods
4.2.1 Mitochondrial Membrane Potential (MMP)
MMP was determined using tetramethylrhodamine (TMRM) [Life Technologies],
a cationic red dye which accumulates in healthy, active mitochondria marking
depolarization. The stock solution was diluted in fluorobrite DMEM to a final
concentration of 20nM, added to cells, and incubated in the dark at room temperature for
45minutes. Afterward, the dye was removed and cells were washed 3 times with warm
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1XPBS. The fluorescence was read at emission 590nm and excitation 573nm. Results are
reported as the normalized intensity to the untreated cells.
4.2.2 Mitochondrial Dehydrogenase Activity
Mitochondrial Dehydrogenase Activity was determined utilizing the MTT [3-(4,5dimethyldiazol-2-yl)2,5 diphenyl Tetrazolium Bromide] [Life Technologies] Assay. It is a
colorimetric assay that evaluates the mitochondrial conversion of the MTT salt. In short,
after 24hr nanoparticle exposure the culture media was aspirated and 5mg/ml MTT
working solution in DMEM incubated on live cells at 37°C for 3hr. Lysis buffer (0.1N HCl
in isopropanol) was added in a 5:1, lysis buffer to MTT solution, ratio. The absorbance
values were read at 570/630nm in an AD340 plate reader [Beckman Coulter, Indianapolis,
IN].
4.2.3 Gene Expression
Total RNA was isolated using Trizol [Life Technologies] according to the
manufacturer’s instructions. The quality and quantity was determined by ND-1000
spectrophotometer [NanoDrop Technologies Wilmington, DE] and reverse transcribed
using iSciptTM cDNA synthesis kit [Bio-Rad Laboratories] by manufacturer’s
instructions.
Quantitative Real Time PCR (RT-PCR) was performed using SYBR Green Master
Mix [Applied Biosystems, Foster City, CA] in an epgradient S Mastercycler [Eppendorf].
The PCR program was set to the following: 10minutes at 95°C, 40-60 cycles of 95°C for
15seconds followed by annealing at 60°C for 15seconds and elongation at 72°C for
60seconds, and finally 95°C for 15seconds to end. The primers of interest obtained from
Integrated NDA Technologies [Coralville, IA] with the following sequences: Mfn1
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(Forward

5’-TCGTGCTGGCAAAGAAGG-3’

CGATCAAGTTCCGGGTTCC-3’),

Mfn2

and

Reverse
(Forward

5’5’-

CGATGTGGTAGTGAGGTTGG-3’ and Reverse 5’-CTCCCATCTTCCACCATTCC3’),

Drp1

(Forward

5’-GAACTACCTTCCGCTGTATCG-3’

and

Reverse

5’-

CGACCACCATCTCCAATTCC-3’). GAPDH (Forward 5’ ATG ATT CTA CCC ACG
GCA AG 3’ and Reverse 5’ CTG GAA GAT GGT GAT GGG TT 3’) was measured as
reference. The ΔΔCT method was utilized for analysis of each sample. Results reported as
normalized to the average expression of untreated cells.
4.2.4 Statistical Analysis
All data is presented as the mean ± the standard deviation. Statistical comparisons
between treatments utilized Sigma Plot ANOVA (Dunnett’s Method) for analysis. Pool
size was as indicated in the figure description.

4.3 Results and Discussion
4.3.1 Mitochondrial Function Disruption
We investigated the effect of TiO2 nanoparticle exposure on MMP (Fig 9A) and
mitochondrial dehydrogenase activity (Fig 9B), assessing the depolarization of
mitochondrial membrane and the activity of succinate dehydrogenase, important markers
of mitochondrial health.26, 47 We observed a 25% decrease in MMP in astrocytes exposed
to P25 in all three concentrations while only 100ppm of anatase demonstrated 25% loss in
MMP. Interestingly, rutile did not have any effect on the MMP even when exposed to
100ppm concentration. Mitochondrial dehydrogenase activity was measured to determine
the damaging effects induced by TiO2 nanoparticle exposure to primary astrocytes. The
exposure of astrocytes to 25ppm, 50ppm, and 100ppm of P25 resulted in 10%, 20%, and
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25% loss in mitochondrial dehydrogenase activity, respectively. Anatase nanoparticles
caused a 10%, 15%, and 25% loss in mitochondrial dehydrogenase activity with 25ppm,
50ppm, and 100 ppm, respectively. Finally, exposure to rutile nanoparticles of 25ppm,
50ppm, and 100ppm lead to a loss of 5%, 10%, and 15% of mitochondrial dehydrogenase
activity, respectively. From this data, we observed that exposure to TiO2 nanoparticles
results in significant mitochondrial stress leading to loss of mitochondria health and
function.
4.3.2 Mitochondrial Dynamics Disruption
Imbalances in mitochondrial dynamics are known to impede cellular bioenergetics
and contribute to numerous neurodegenerative diseases.64 To investigate the effect of
nanoparticle treatment on mitochondrial dynamics, we measured the relative gene
expressions of Mfn1, Mfn2, and Drp1, markers associated with mitochondrial fusion and
fission events (Fig 10). Mfn1 and Mfn2 are essential proteins for the fusion process while
Drp1 is an essential protein for the fission process. Changes in transcript levels of Mfn1
and Mfn2 have been reported to correlate with changes in mitochondrial dynamics.65 At
low concentrations of P25 (25ppm and 50ppm), we observed a significant up-regulation of
Mfn1 and Mfn2 transcripts while no significant change in Drp1 was observed. These
findings imply a tendency toward fusion in response to TiO2 nanoparticle treatment. In
astrocytes exposed to 100ppm of P25, anatase, and rutile nanoparticles, Drp1 was upregulated, which indicates the activation of the fission process leading to mitochondrial
fragmentation and cell death. These results indicate that TiO2 nanoparticles induce stress
on the mitochondria which has a concentration dependent response similar to that proposed
by Van der Bliek66. However, further study will need to be conducted to know if the
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prolonged stress from low concentration TiO2 nanoparticles can eventually lead to
apoptosis and result in neurodegeneration.

Figure 9: Mitochondrial Stress triggered in Astrocytes after 24hr exposure. Decrease in
MPP (A) and mitochondrial dehydrogenase activity loss (B) indicate loss of mitochondrial
health due to nanoparticle stress. N=5, “*” indicates P<0.05 compared to untreated.

38

Figure 10: Mitochondrial dynamics interruption in astrocytes after 24hr exposure.
Increase in Mfn1 and 2 and Drp1 indicate a deviation from normal mitochondrial dynamic
balance toward hyperfusion in 25ppm and 50ppm treated cells and fission in 100ppm
treated cells. N = 3 “*” indicates P<0.05.
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4.4 Conclusion
We observed evidence of concentration dependent decrease in mitochondrial health
and response of mitochondrial dynamics after 24hr exposure to TiO2 nanoparticles. Low
concentration (25ppm and 50ppm) nanoparticles, although causing very little change in
mitochondrial health, brought about changes in DRPs’ expression, indicative of
mitochondrial fusion. However, exposure to high concentration (100ppm) TiO2
nanoparticles caused marked decrease in mitochondrial health and resulted in DRPs’
expression patterns reflecting on increased fission. These results confirm that
mitochondrial dynamics are disrupted by stress induced by low levels of TiO2 nanoparticles
which may play a role in loss of important astrocyte functions and neurodegeneration.
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5

Chapter 5 Recommendation for Future Work

This thesis has assessed and confirmed the negative sub-toxic effect of TiO2
nanoparticles in primary rat astrocytes in vitro. At concentrations below that which would
induce significant cell death within 24hr, astrocytes experience disruption of mitochondrial
dynamics and function, generation of ROS and loss of glutamate uptake and transporter
expression. These observations are important preliminary observations to uncover the role
that stress induced by low concentration TiO2 may play in the onset and progression of
neurodegenerative disease however there are many other observation which would further
support and provide greater understanding which I will describe here after.
(1) Further understanding of the effect of TiO2 on bioenergetics impairment
of astrocytes. We have observed early indication of mitochondrial function impairment
and dynamics disruption in primary astrocytes. However, it would be informative to look
more into this subject through other avenues further probing mitochondrial function
impairment. The extent of mitochondrial function impairment could further be quantified
by loss in ATP production, glucose uptake and lactate production since these are crucial
functions of the mitochondria which astrocytes and neurons rely on for energy to support
vital cellular processes. Furthermore, we could visualize the extent of mitochondrial
dynamics impairment at low concentration in 24 hours by viewing mitochondrial
morphology and quantifying protein. This would indicate the extent that the gene
expression correlates to the physical changes in the organelle. This study could also be
extended beyond 24 hours to find the time requirement for low concentration exposure to
result in protein and mitochondrial structure change. As change in gene expression is
thought to be an early sign proceeding morphology change this result would validate this
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practice. The time dependent exposure study would also indicate whether the hyperfusion
experienced by astrocytes will lead to apoptosis in the chronic presence of low
concentration TiO2 nanoparticles.
(2) Further understanding of the effect of TiO2 on other cell types of the brain.
Other cell types of the brain, such as microglia and oligodendrocytes, perform very specific
roles in neuron function and development and could also be disrupted by the presence of
sub-toxic concentrations of TiO2. Therefore the level of functional disruption should also
be assessed in them. Microglia are the macrophages of the brain and therefore seek out
foreign materials and initiate immune response in brain tissue. They are the key defense
against infection, inflammation and neurodegeneration and would then play a key role in
response to disruption caused by low levels of TiO2.67 A few studies have assessed the
increase in ROS generation and increased gene expression in pathways associated with
inflammation, cell proliferation, and oxidative stress in microglia and mediated toxicity of
TiO2 nanoparticles in neurons.35, 40, 68 Oligodendrocytes support the survival and growth of
neurons by expressing growth factors and providing insulation to the axon of neurons
through the myelin sheath.69 The dysfunction of oligodendrocytes is most commonly
known for its presence in multiple sclerosis and leukodystrophies however studies show
that it may be implemented in other pathways leading to improper neuronal development
and function. One study observed significant uptake of TiO2 nanoparticles by
oligodendrocytes cell line, OLN93, but further knowledge of the impact this has on the cell
function could be crucial to understanding if nanoparticles have an impact in brain
development and neurodegeneration.70 As the reaction of cell types to the presence of TiO2

42
can be widely varied it is important to understand how each cell type responds in order to
understand the true impact of TiO2 nanoparticles in the brain.
(3) The effect of TiO2 nanoparticles on neuron-astrocyte communication.
Another important future avenue for this study is to understand the ramifications of TiO2
nanoparticles on cellular communications, especially those between neurons and
astrocytes. Since astrocytes receive communication from neurons for restoration of
homeostasis and tissue repair, the addition of neuron signals to the culture may alter the
astrocyte response and sensitivity to TiO2 nanoparticles.71 Current methods available for
co-culture of neurons and astrocytes include transwell, conditioned media and random coculture.46, 72 Each of these methods have their strengths as far as the extent of cellular
communication allowance. Transwell and conditioned media experiments only allow for
chemical communication over a distance while random co-culture allows for physical
contact and short range communication. There are also strengths and weaknesses in each
method for mimicking the cell-cell-nanoparticle interaction. Transwell and conditioned
media can allow for only the cellular signal in response to nanoparticles to reach the second
cell type while random co-culture would complicate communication by signal and
nanoparticle interaction while providing the closest indication of in vivo interaction.
Therefore, a co-culture study with nanoparticles would most likely benefit from a
combination of results utilizing different multiple co-culture methods.
There is much still to be learned about the interaction of nanoparticles in the brain
and how this may contribute to a number of developmental and neurodegenerative
disorders. These studies are important to the understanding of potential impact and
treatment as well as insightful into the basic understanding of brain function.
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